190 related articles for article (PubMed ID: 36902376)
21. Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: possible role of hydrogen peroxide.
Vidrio H; Medina M; González-Romo P; Lorenzana-Jiménez M; Díaz-Arista P; Baeza A
J Pharmacol Exp Ther; 2003 Nov; 307(2):497-504. PubMed ID: 12970383
[TBL] [Abstract][Full Text] [Related]
22. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity.
Conklin DJ; Langford SD; Boor PJ
Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
Deng Y; Yu PH
Anal Biochem; 1999 May; 270(1):97-102. PubMed ID: 10328770
[TBL] [Abstract][Full Text] [Related]
24. Aminoacetone metabolism by semicarbazide-sensitive amine oxidase in rat aorta.
Lyles GA; Chalmers J
Biochem Pharmacol; 1995 Jan; 49(3):416-9. PubMed ID: 7857329
[TBL] [Abstract][Full Text] [Related]
25. 2-Bromoethylamine as a potent selective suicide inhibitor for semicarbazide-sensitive amine oxidase.
Yu PH; Davis BA; Deng Y
Biochem Pharmacol; 2001 Mar; 61(6):741-8. PubMed ID: 11266660
[TBL] [Abstract][Full Text] [Related]
26. Benzylamine antihyperglycemic effect is abolished by AOC3 gene invalidation in mice but not rescued by semicarbazide-sensitive amine oxidase expression under the control of aP2 promoter.
Grès S; Bour S; Valet P; Carpéné C
J Physiol Biochem; 2012 Dec; 68(4):651-62. PubMed ID: 22547093
[TBL] [Abstract][Full Text] [Related]
27. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase.
Lyles GA
Prog Brain Res; 1995; 106():293-303. PubMed ID: 8584666
[TBL] [Abstract][Full Text] [Related]
28. Benzylamine and methylamine, substrates of semicarbazide-sensitive amine oxidase, attenuate inflammatory response induced by lipopolysaccharide.
Lin Z; Li H; Luo H; Zhang Y; Luo W
Int Immunopharmacol; 2011 Aug; 11(8):1079-89. PubMed ID: 21414430
[TBL] [Abstract][Full Text] [Related]
29. Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus.
Ekblom J
Pharmacol Res; 1998 Feb; 37(2):87-92. PubMed ID: 9572061
[TBL] [Abstract][Full Text] [Related]
30. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes.
Callingham BA; Crosbie AE; Rous BA
Prog Brain Res; 1995; 106():305-21. PubMed ID: 8584667
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
[TBL] [Abstract][Full Text] [Related]
32. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
33. Diabetes and semicarbazide-sensitive amine oxidase (SSAO) activity: a review.
Obata T
Life Sci; 2006 Jun; 79(5):417-22. PubMed ID: 16487546
[TBL] [Abstract][Full Text] [Related]
34. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Yu PH; Zuo DM
Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
[TBL] [Abstract][Full Text] [Related]
35. Properties of mammalian tissue-bound semicarbazide-sensitive amine oxidase: possible clues to its physiological function?
Lyles GA
J Neural Transm Suppl; 1994; 41():387-96. PubMed ID: 7931255
[TBL] [Abstract][Full Text] [Related]
36. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
Mercier N; Moldes M; El Hadri K; Fève B
Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
[TBL] [Abstract][Full Text] [Related]
37. The role of plasma semicarbazide-sensitive amine oxidase in allylamine and beta-aminopropionitrile cardiovascular toxicity: mechanisms of myocardial protection and aortic medial injury in rats.
Conklin DJ; Trent MB; Boor PJ
Toxicology; 1999 Nov; 138(3):137-54. PubMed ID: 10593505
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of methylamine by semicarbazide-sensitive amine oxidase in white and brown adipose tissue of the rat.
Conforti L; Raimondi L; Lyles GA
Biochem Pharmacol; 1993 Aug; 46(4):603-7. PubMed ID: 8363633
[TBL] [Abstract][Full Text] [Related]
39. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
[TBL] [Abstract][Full Text] [Related]
40. Inhibitor sensitivity of human serum and vascular semicarbazide-sensitive amine oxidases.
Mészáros Z; Csányi A; Vallus G; Szombathy T; Karádi I; Magyar K
Neurobiology (Bp); 2000; 8(2):215-23. PubMed ID: 11061216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
